Pulmonx (LUNG) Receivables - Net (2019 - 2025)

Pulmonx (LUNG) has reported Receivables - Net for 7 consecutive years, with $12.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Receivables - Net fell 7.99% year-over-year to $12.1 million in Q4 2025; TTM through Dec 2025 was $12.1 million, a 7.99% decrease from a year earlier, with the FY2025 full-year figure at $12.1 million, down 7.99% from the prior year.
• Receivables - Net was $12.1 million for Q4 2025 at Pulmonx, down from $13.8 million in the prior quarter.
• Over five years, Receivables - Net peaked at $15.9 million in Q2 2025 and troughed at $5.1 million in Q1 2021.
• A 5-year average of $9.9 million and a median of $9.5 million in 2023 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net surged 55.2% in 2021 and decreased 7.99% in 2025, its largest moves.
• Over 5 years, Receivables - Net stood at $6.6 million in 2021, then jumped by 32.23% to $8.7 million in 2022, then surged by 39.51% to $12.1 million in 2023, then grew by 8.38% to $13.1 million in 2024, then fell by 7.99% to $12.1 million in 2025.
• The last three Receivables - Net figures came in at $12.1 million (Q4 2025), $13.8 million (Q3 2025), and $15.9 million (Q2 2025), per Business Quant data.